Tonsillar Neoplasms

扁桃体肿瘤
  • 文章类型: Case Reports
    背景:伴有扁桃体受累的结外自然杀伤/T细胞淋巴瘤(ENKTL)并不常见,尤其是儿童。
    方法:一名13岁女孩出现不明原因的喉咙痛超过2个月,伴有间歇性发热和化脓性扁桃体炎。鼻咽镜检查显示咽部肿块。增强计算机断层扫描(CT)扫描显示扁桃体肥大和点状钙化。左扁桃体慢性化脓性肉芽肿性炎症伴假性上皮鳞状上皮增生,在右侧扁桃体中检测到化脓性肉芽肿性炎症和少量T淋巴细胞。免疫组化结果显示CD2+,CD3+,CD4+,CD5+,CD8+,颗粒酶B+,和TIA-1+。Ki-67增殖指数为20%。病例显示T细胞受体基因重排。最后,该病例被诊断为ENKTLII期扁桃体受累。患者接受SMILE方案化疗6个周期,并在随访中显示完全缓解且无复发。
    结论:我们介绍了一例罕见的ENKTL患儿扁桃体受累。患者对SMILE化疗显示完全反应,无复发。
    BACKGROUND: Extranodal natural killer/T-cell lymphoma (ENKTL) with tonsil involvement is not common, especially in children.
    METHODS: A 13-year-old girl presented with an unexplained sore throat for more than 2 months, together with intermittent fever and suppurative tonsilitis. Nasopharyngoscopy revealed a pharyngeal mass. Enhanced computed tomography (CT) scan showed tonsillar hypertrophy and punctate calcification. Chronic pyogenic granulomatous inflammation with pseudoepithelial squamous epithelial hyperplasia was observed in left tonsil, and pyogenic granulomatous inflammation and a small number of T-lymphoid cells were detected in the right tonsil. The immunohistochemical results showed CD2+, CD3+, CD4+, CD5+, CD8+, granzyme B+, and TIA-1+. The Ki-67 proliferation index was 20%. The case showed T cell receptor gene rearrangement. Finally, the case was diagnosed as ENKTL of stage II with tonsil involvement. The patient received 6 cycles of chemotherapy with SMILE regimen, and showed complete response with no recurrence in the follow-up.
    CONCLUSIONS: We presented a rare case of ENKTL with tonsil involvement in a child. The patient showed complete response to the SMILE chemotherapy with no recurrence.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    背景:滑膜肉瘤是一种罕见的软组织恶性肿瘤,偶尔在头颈部发现。诊断需要涉及临床表现的多学科方法,适当的影像学研究和组织学确认,进行分子测试以进行最终鉴定。治疗需要手术切除,并根据需要进行辅助治疗。
    方法:一名33岁的男性患者表现为球形感并伴有右侧颈部肿胀。临床上发现他有右扁桃体增大并向后延伸。因此,他接受了右扁桃体切除术和咽成形术。组织病理学检查显示与滑膜肉瘤一致的双相肿瘤,通过免疫组织化学和荧光原位杂交证实。
    结论:扁桃体滑膜肉瘤是一种诊断挑战,需要高度怀疑和综合评价。文献中只记录了20个以前发表的案例,对这种罕见表现的认识对于及时诊断和适当管理至关重要.多学科医疗团队之间的合作和正在进行的研究工作对于优化诊断准确性至关重要。治疗功效,以及这种罕见恶性肿瘤的患者预后。
    BACKGROUND: Synovial sarcoma is a rare soft tissue malignancy, occasionally found in the head and neck region. The diagnosis necessitates a multidisciplinary approach involving the clinical presentation, proper imaging studies and histological confirmation, with molecular testing for definitive identification. Treatment entails surgical resection with adjuvant therapies as needed.
    METHODS: A 33-year-old male patient presented with globus sensation concomitant with right-sided neck swelling. He was clinically found to have right tonsil enlargement with posterior extension. Therefore, he underwent right tonsillectomy with pharyngoplasty. Histopathological examination revealed a biphasic tumor consistent with synovial sarcoma, confirmed by immunohistochemistry and fluorescence in situ hybridization.
    CONCLUSIONS: Tonsillar synovial sarcoma represents a diagnostic challenge, requiring a high index of suspicion and comprehensive evaluation. With only twenty previously published cases documented in the literature, awareness of this rare presentation is crucial for prompt diagnosis and appropriate management. Collaboration among multidisciplinary healthcare teams and ongoing research efforts are essential for optimizing diagnostic accuracy, treatment efficacy, and patient outcomes in this rare malignancy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    放射治疗通常伴随着照射区域的皮肤毒性和对周围色素沉着区域的皮肤组织细胞的辐射诱导的DNA损伤。该病例报告描述了一名放射性皮肤损伤患者,该患者接受了伤口治疗和心理干预,效果满意。2021年1月18日,一名60岁的妇女因扁桃体癌的碳离子放疗引起的放射性皮肤损伤而入院。患者接受伤口修复结合心理干预(每次换药30分钟)。在1个月的时间里,伤口面积从11×12cm2减少到1×1cm2,伤口症状(渗出物,血液气味,伤口感染,伤口边缘脱水和卷曲,伤口周围皮肤脱皮,干燥度,和角化过度)改善。患者的焦虑因子得分从18降至1,抑郁因子得分从16降至3。患者治疗1个月后出院时,她有令人满意的自我形象和正常的社交活动。
    UNASSIGNED: Radiation therapy is often accompanied by skin toxicity in the irradiated area and radiation-induced DNA damage to skin tissue cells in the surrounding pigmented area. This case report describes a patient with radiation-induced skin injury who received wound treatment and psychological intervention with satisfactory results. A 60-year-old woman was admitted to the authors\' hospital on January 18, 2021, with radiation-induced skin injury caused by carbon ion radiotherapy for tonsillar carcinoma. The patient underwent wound repair combined with psychological intervention (30 minutes per dressing change). Over a period of 1 month, the wound area was reduced from 11 × 12 cm2 to 1 × 1 cm2, and wound symptoms (exudate, blood odor, wound infection, wound edge dehydration and curling, periwound skin peeling, dryness, and hyperkeratosis) improved. The patient\'s anxiety factor scores decreased from 18 to 1, and her depression factor scores decreased from 16 to 3. When the patient was discharged from the hospital after 1 month of treatment, she had a satisfactory self-image and normal social activities.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: English Abstract
    Objectives: To analyze the location, discovery time and possible causes of cases of cervical cystic lymph node metastasis with an unknown primary misdiagnosed as branchial cleft carcinoma. Methods: A retrospective analysis was performed on clinical and pathological data of 15 patients misdiagnosed as branchiogenic carcinoma at Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College between January 2000 and December 2020. Results: Among the 15 patients, 6 were nasopharyngeal squamous cell carcinoma, 4 tonsil squamous cell carcinoma, 2 tongue root squamous cell carcinoma, 2 hypopharyngeal squamous cell carcinoma and 1 thyroid papillary carcinoma. The median time from the diagnosis of branchial cleft carcinoma to the discovery of primary lesions was 3.58 months (0-76 months). The causes of misdiagnosis might be the lack of experience in the diagnosis and treatment of branchial cleft carcinoma, and not enough attention to comprehensive examination and close follow-up. Conclusions: Different from oropharyngeal cancer reported internationally, the proportion of misdiagnosed cases with nasopharyngeal carcinoma as the primary site in the current article is higher. As a country with a high incidence of nasopharyngeal carcinoma, the examination of nasopharynx should not be taken lightly. Most hidden cases can be found in the comprehensive examination in a short time, while a few cases need long-term follow-up. Finding the primary sites should not rely too much on imaging examination, and we cannot ignore the importance of clinical physical examination.
    目的: 探讨鳃裂癌的原发灶发生部位、发现时间及可能的误诊原因,为临床诊治提供经验。 方法: 回顾性收集2000年1月至2020年12月中国医学科学院肿瘤医院收治的经病理诊断为鳃裂癌患者的临床病理资料,对15例误诊为鳃裂癌患者的临床资料以及临床诊疗进行回顾性分析。 结果: 15例误诊患者中,鼻咽鳞状细胞癌6例,扁桃体鳞状细胞癌4例,舌根鳞状细胞癌2例,下咽鳞状细胞癌2例,甲状腺乳头状癌1例。从诊断鳃裂癌到发现原发灶的中位时间为3.58个月(0~76个月)。误诊原因可能是对于鳃裂癌及发生囊性变的颈部淋巴结转移癌的诊治经验不足以及没有重视全面检查及密切随诊。 结论: 以鼻咽癌为原发灶的病例误诊为鳃裂癌的占比较高,作为鼻咽癌高发国家,一定要重视鼻咽部位的检查。多数隐匿患者能够于术后完善检查中发现原发灶,少数患者需长期随访观察。寻找原发灶不应过度依赖影像学检查,临床查体的重要性不可忽视。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    颌骨坏死是与贝伐单抗相关的公认并发症。这里,我们介绍了1例扁桃体鳞状细胞癌患者,在调强放疗后出现了轻微的皮肤纤维化.随后,患者在接受两个周期的贝伐单抗治疗后发展为直肠腺癌,并发生颌骨坏死.密切监测,伴随着彻底的检查,以发现颌骨坏死的早期迹象,对于在头颈部接受放射治疗并且正在接受贝伐单抗或其他已知与颌骨坏死相关的药物的患者,应考虑。
    Osteonecrosis of the jaw is a recognized complication associated with bevacizumab. Here, we present a patient with squamous cell carcinoma of the tonsil who experienced minimal skin fibrosis following intensity-modulated radiation therapy. Subsequently, the patient developed rectal adenocarcinoma and encountered osteonecrosis of the jaw after receiving two cycles of bevacizumab. Close monitoring, accompanied by thorough examination to detect early signs of osteonecrosis of the jaw, should be considered for patients who have undergone radiation therapy in the head and neck region and are receiving bevacizumab or other medications known to be associated with osteonecrosis of the jaw.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: English Abstract
    Objective: To analyze the ultrasonic features of tonsillar lymphoma to improve the diagnostic accuracy. Methods: The clinical, pathological and ultrasonic data of nine patients with tonsillar lymphoma confirmed by pathology at Tianjin Medical University Cancer Institute and Hospital during June 2015 and June 2022 were analyzed retrospectively, and the characteristics of their ultrasonic images were summarized. Results: All 9 cases of tonsil lymphoma were unilateral tonsil disease, including 4 cases on the left side and 5 cases on the right side. The average maximum diameter of tonsil lymphoma in 9 cases was 4.32 cm. There were 3 cases with simultaneous involvement of tonsil and cervical lymph nodes, all of which were ipsilateral lymph nodes. Gray scale ultrasound showed that the lesions were hypoechoic, with clear boundaries in 7 cases and unclear boundaries in 2 cases. The shape was full and irregular in 5 cases and oval in 4 cases. The echo was uniform in 7 cases and uneven in 2 cases. Color Doppler ultrasonography showed abundant internal blood flow signal in 1 case, a little dotted linear internal blood flow signal in 5 cases, and no obvious internal blood flow signal in 3 cases. Conclusions: The ultrasonic features of tonsillar lymphoma include hypoechoic area, clear boundary, full shape, irregular and uniform internal echo, no or low linear signal of internal blood flow. Ultrasonography is of great value in the diagnosis of this disease and can help clinical decision-making.
    目的: 分析扁桃体淋巴瘤的超声特征,提高诊断的准确性。 方法: 回顾性分析2015年6月至2022年6月天津市肿瘤医院经病理证实的9例扁桃体淋巴瘤患者的临床、病理资料及超声特征。 结果: 9例扁桃体淋巴瘤中,弥漫性大B细胞淋巴瘤7例,伯基特淋巴瘤2例。均为单侧扁桃体发病,左侧4例,右侧5例,平均最大径为4.32 cm。3例伴有颈部淋巴结转移,均为同侧淋巴结。灰阶超声示,病灶形态饱满、不规则5例,呈卵圆形4例;边界清晰7例,边界不清晰2例;病灶均为低回声,回声均匀7例,回声不均匀2例。彩色多普勒血流显像示,1例病灶内部血流信号较丰富,5例病灶内部少许点线状血流信号,3例内部无明显血流信号。 结论: 扁桃体淋巴瘤的超声表现多形状饱满、不规则,边界清楚,病灶低回声,内部回声均匀,无血流或少许点线状血流信号。超声对扁桃体淋巴瘤的诊断具有重要价值,可为临床决策提供帮助。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Systematic Review
    研究表明,扁桃体切除术可能会改变口咽癌(OPC)的风险。我们系统地回顾了证据和汇总数据,以检查这种关联。
    PubMed,Embase,和Scopus被搜索到2023年4月25日。研究报告了扁桃体切除术与任何部位的口鼻咽癌风险之间的关联。
    有5项研究符合条件。所有患者均检查了扁桃体和舌根(BOT)癌的风险,并有扁桃体切除术史。在数据的荟萃分析中,既往扁桃体切除术史与扁桃体癌风险显著降低相关.第二次荟萃分析显示,扁桃体切除术的历史并没有显着改变BOT癌症的风险。然而,排除一项研究后,结果显示,有扁桃体切除术史的患者发生BOT癌的风险增加.
    文献中的现有数据表明,扁桃体切除术可以降低扁桃体癌的风险,但不会改变BOT癌的风险。需要进一步的研究来探索扁桃体切除术与OPC风险之间的关系。
    UNASSIGNED: Studies have demonstrated that tonsillectomy may alter the risk of oropharyngeal cancer (OPC). We systematically reviewed the evidence and pooled data to examine such an association.
    UNASSIGNED: PubMed, Embase, and Scopus were searched up to 25th April 2023. Studies reporting an association between tonsillectomy and oropharyngeal cancer risk at any site were included.
    UNASSIGNED: Five studies were eligible. All examined the risk of tonsillar and base of the tongue (BOT) cancer with prior history of tonsillectomy. On meta-analysis of the data, prior history of tonsillectomy was associated with a significantly decreased risk of tonsillar cancer. The second meta-analysis showed that history of tonsillectomy did not significantly alter the risk of BOT cancer. However, after exclusion of one study, the results showed an increased risk of BOT cancer with a history of tonsillectomy.
    UNASSIGNED: The scarce data available in the literature suggests that tonsillectomy may reduce the risk of tonsillar cancer but does not alter the risk of BOT cancer. Further studies are needed to explore the association between tonsillectomy and the risk of OPC.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:本研究旨在比较[68Ga]Ga-DOTA-FAPI-04和[18F]FDGPET/CT显像对扁桃体癌患者原发灶和转移淋巴结的诊断价值。
    方法:回顾性纳入21例扁桃体癌患者,这些患者在我们中心两周内接受了[68Ga]Ga-DOTA-FAPI-04和[18F]FDGPET/CT扫描。使用Mann-WhitneyU检验比较了两种示踪剂的最大标准化摄取值(SUVmax)和肿瘤背景比(TBR)。此外,灵敏度,特异性,并分析了两种方法诊断转移性淋巴结的准确性。
    结果:在检测原发性病变时,[68Ga]Ga-DOTA-FAPI-04PET/CT(20/22)的效率高于[18F]FDGPET/CT(9/22)。尽管[68Ga]Ga-DOTA-FAPI-04摄取(SUVmax,5.03±4.06)低于[18F]FDG摄取(SUVmax,7.90±4.84,P=0.006),[68Ga]Ga-DOTA-FAPI-04改善了原发性肿瘤和对侧正常扁桃体组织之间的区别。[68Ga]Ga-DOTA-FAPI-04PET/CT的TBR(3.19±2.06)显著高于[18F]FDGPET/CT(1.89±1.80)(p<0.001)。在淋巴结分析中,[68Ga]Ga-DOTA-FAPI-04和[18F]FDGPET/CT之间的SUVmax和TBR没有显着差异(7.67±5.88vs.8.36±6.15,P=0.498和5.56±4.02。4.26±3.16,P=0.123)。[68Ga]Ga-DOTA-FAPI-04PET/CT诊断颈部淋巴结转移的特异性和准确性均高于[18F]FDGPET/CT(均P<0.05)。
    结论:与[18F]FDG相比,[68Ga]Ga-DOTA-FAPI-04的可用性提高了[18F]FDG的原发灶检出率和颈部转移淋巴结的诊断准确性,从而补充了[18F]FDG的诊断结果。
    BACKGROUND: This study aimed to compare the diagnostic value of [68 Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT imaging for primary lesions and metastatic lymph nodes in patients with tonsil cancer.
    METHODS: Twenty-one tonsil cancer patients who underwent [68 Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT scans within two weeks in our centre were retrospectively enrolled. The maximum standardized uptake value (SUVmax) and tumor-to-background ratio (TBR) of the two tracers were compared by using the Mann‒Whitney U test. In addition, the sensitivity, specificity, and accuracy of the two methods for diagnosing metastatic lymph nodes were analysed.
    RESULTS: In detecting primary lesions, the efficiency was higher for [68 Ga]Ga-DOTA-FAPI-04 PET/CT (20/22) than for [18F]FDG PET/CT (9/22). Although [68 Ga]Ga-DOTA-FAPI-04 uptake (SUVmax, 5.03 ± 4.06) was lower than [18F]FDG uptake (SUVmax, 7.90 ± 4.84, P = 0.006), [68 Ga]Ga-DOTA-FAPI-04 improved the distinction between the primary tumor and contralateral normal tonsillar tissue. The TBR was significantly higher for [68 Ga]Ga-DOTA-FAPI-04 PET/CT (3.19 ± 2.06) than for [18F]FDG PET/CT (1.89 ± 1.80) (p < 0.001). In lymph node analysis, SUVmax and TBR were not significantly different between [68 Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT (7.67 ± 5.88 vs. 8.36 ± 6.15, P = 0.498 and 5.56 ± 4.02 vs. 4.26 ± 3.16, P = 0.123, respectively). The specificity and accuracy of [68 Ga]Ga-DOTA-FAPI-04 PET/CT were higher than those of [18F]FDG PET/CT in diagnosing metastatic cervical lymph nodes (all P < 0.05).
    CONCLUSIONS: The availability of [68 Ga]Ga-DOTA-FAPI-04 complements the diagnostic results of [18F]FDG by improving the detection rate of primary lesions and the diagnostic accuracy of cervical metastatic lymph nodes in tonsil cancer compared to [18F]FDG.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: English Abstract
    Objective: To evaluate the efficacy of neoadjuvant chemoimmunotherapy (NACI) combined with transoral robotic surgery (TORS) in the treatment of locally advanced oropharyngeal squamous cell carcinoma (OPSCC). Methods: This was a retrospective study of 15 patients with locally advanced OPSCC who underwent TORS after neoadjuvant therapy (NAT) at the Department of Otolaryngology-Head and Neck Surgery of Sun Yat-sen Memorial Hospital of Sun Yat-sen University from April 2019 to February 2023. There were 12 males and 3 females, aged 31 to 74 years. Twelve cases were tonsil cancer, and 3 cases were tongue base cancer. There were 11 cases in stage Ⅲ and 4 cases in stage Ⅳ. Two patients received neoadjuvant chemotherapy and 13 patients received NACI, with 2 to 3 cycles, and all patients underwent TORS after multidisciplinary team consultation. The clinicopathological characteristics, surgical outcomes, and oncological results were summarized. Results: All surgeries were successfully completed with negative surgical margins, and no case was required conversion surgery. All patients were fed via nasogastric tubes postoperatively, with a median gastric tube stay of 7 days (range: 2-60 days). No tracheotomy was applied. There were no major complications such as postoperative bleeding. Pathological complete response (pCR) was found in 10 cases (76.9%) among the 13 patients with NACI. The follow-up time was 21 months (range: 10-47 months), and there was no death or distant metastasis. One patient with rT0N3M0 tonsil cancer had local recurrence 5 months after surgery. The 2-year overall survival and 2-year disease-free survival were respectively 100.0% and 93.3% in the 15 patients. Conclusion: NACI combined with TORS provides a safe, effective and minimally invasive treatment for patients with locally advanced oropharyngeal squamous cell carcinoma.
    目的: 探讨新辅助治疗联合经口机器人手术(transoral robotic surgery,TORS)治疗局部晚期口咽鳞状细胞癌(简称鳞癌)的初步疗效。 方法: 回顾性分析中山大学孙逸仙纪念医院耳鼻咽喉头颈外科2019年4月至2023年2月,新辅助治疗后行TORS的15例局部晚期口咽鳞癌病例,其中男性12例,女性3例,年龄31~74岁。扁桃体癌12例,舌根癌3例;Ⅲ期11例,Ⅳ期4例。新辅助化学治疗2例,新辅助化学联合免疫治疗13例;疗程为2~3周期,均经多学科会诊通过后进行TORS。总结临床病理学特点、手术及肿瘤学结果。 结果: 手术均顺利完成,病理切缘均阴性,无中转手术病例。患者术后均鼻饲饮食,胃管停留中位时间为7 d(范围:2~60 d);无气管切开病例,无术后出血等严重并发症。13例行新辅助化学免疫治疗病例中,10例(76.9%)术后病理完全缓解。随访时间中位数为21个月(范围:10~47个月),无死亡及远处转移病例,1例rT0N3M0扁桃体癌患者在术后5个月发生局部复发。15例患者2年总生存率为100.0%,2年无病生存率为93.3%。 结论: 新辅助治疗联合TORS为局部晚期口咽鳞癌患者提供一种有效且微创的治疗方法。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    本文报道1例发生于青年男性的扁桃体滤泡树突状细胞肉瘤(follicular dendritic cell sarcoma,FDCS)。患者男性,35岁,因“发现右扁桃体肿物20 d”就诊。术前活检提示右侧扁桃体恶性肿瘤可能性大,增强磁共振成像(magnetic resonance imaging,MRI)提示右侧扁桃体肿大,可见软组织肿物突向口咽腔,表面见溃疡影。患者在全身麻醉下行低温等离子右侧扁桃体及肿瘤切除术,术后病理确诊为FDCS。患者术后第8天出院,出院至今已规律随访3年,复查未见肿瘤复发及转移,预后良好。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号